![Jack Taunton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jack Taunton
Direttore/Membro del Consiglio presso Terremoto Biosciences, Inc.
Posizioni attive di Jack Taunton
Società | Posizione | Inizio | Fine |
---|---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | - | - |
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jack Taunton
Precedenti posizioni note di Jack Taunton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Direttore operativo | - | - |
Cedilla Therapeutics, Inc.
![]() Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Fondatore | 06/09/2017 | - |
PRINCIPIA BIOPHARMA INC. | Fondatore | 28/10/2008 | - |
Corporate Officer/Principal | 28/10/2008 | - | |
KEZAR LIFE SCIENCES, INC. | Fondatore | 19/02/2015 | - |
GLOBAL BLOOD THERAPEUTICS, INC. | Fondatore | 01/02/2011 | - |
Formazione di Jack Taunton
Trinity University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
Founder | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KEZAR LIFE SCIENCES, INC. | Health Technology |
Aziende private | 4 |
---|---|
Global Blood Therapeutics, Inc.
![]() Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Principia Biopharma, Inc.
![]() Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Cedilla Therapeutics, Inc.
![]() Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Jack Taunton
- Esperienza